| 651 |
Suppression, Estrogen receptor (ER) activity leads to Impaired, Spermatogenesis via epigenetic modifications |
John Frisch |
BY-SA |
1046: Suppression, Estrogen receptor (ER) activity
|
1758: Impaired, Spermatogenesis
|
|
|
| 650 |
Polystyrene nanoplastic-induced PPAR signaling dysregulation leading to hepatic steatosis and metabolic dysfunction via oxidative stress-driven lipid metabolism reprogramming |
Ying Wang |
All rights reserved |
None
|
None
|
|
|
| 649 |
Photocatalytic ROS generation by titanium dioxide nanoparticles leading to visual dysfunction and reduced larval survival via retinal photoreceptor oxidative damage |
Ying Wang |
All rights reserved |
None
|
None
|
|
|
| 648 |
Nanomaterial-induced ferritinophagy activation leading to Parkinson's-like motor dysfunction via iron-dependent ferroptotic neurodegeneration |
Ying Wang |
All rights reserved |
None
|
None
|
|
|
| 647 |
ROS formation leading to growth inhibition modulated by the Keap1–Nrf2 antioxidant response |
Ying Wang |
All rights reserved |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 646 |
Binding and activation of AhR/PPARγ lead to lipid metabolism disorders |
Shiheng Gui |
BY-SA |
2 MIEs
|
1995: Abnormal lipid metabolism
|
|
|
| 645 |
Binding and activation of AhR lead to cardiovascular aging |
Shiheng Gui |
BY-SA |
2430: Aryl hydrocarbon receptor(AhR)activation
|
2438: Increase, Cardiovascular aging
|
|
|
| 644 |
Bulky DNA adducts leading to chromosomal aberrations and mutations |
Beckner Andersano |
BY-SA |
1879: Bulky DNA adducts, increase
|
2 AOs
|
|
|
| 642 |
Intestinal FXR inhibition leading to steatohepatitis via gut‑liver axis dysregulation |
Jung-Hwa Oh |
BY-SA |
2421: Inhibition, Intestinal FXR
|
1489: Increase, Steatohepatitis
|
|
|
| 641 |
Activation, estrogen receptor alpha leads to increased, phenotypic female-biased sex ratio via increased, differentiation to ovaries |
John Frisch |
BY-SA |
1065: Activation, estrogen receptor alpha
|
2418: Increased, phenotypic female-biased sex ratio
|
|
|
| 640 |
Activation, estrogen receptor alpha leads to decreased fertility via prolonged estrus cycle |
John Frisch |
BY-SA |
1065: Activation, estrogen receptor alpha
|
406: decreased, Fertility
|
|
|
| 639 |
Activation, estrogen receptor alpha leads to precocious puberty via increased kisspeptin release |
John Frisch |
BY-SA |
1065: Activation, estrogen receptor alpha
|
2415: Precocious puberty
|
|
|
| 638 |
Co-exposure to microplastics and cadmium leading to progression from NAFLD to liver tumorigenesis |
Wei Mu |
BY-SA |
3 MIEs
|
2 AOs
|
|
|
| 637 |
Activation, estrogen receptor alpha leads to increased uterine weight via earlier proliferation of cells of the uterine lining |
John Frisch |
BY-SA |
1065: Activation, estrogen receptor alpha
|
2413: Increased, uterine weight
|
|
|
| 636 |
Increase in reactive oxygen species (ROS) leading to human amyotrophic lateral sclerosis (ALS) |
Shihori Tanabe |
All rights reserved |
1115: Increase, Reactive oxygen species
|
2416: human amyotrophic lateral sclerosis (ALS)
|
|
|
| 635 |
Increased adrenal glucocorticoid production leading to MASLD progression (6) |
You Song |
BY-SA |
None
|
None
|
|
|
| 634 |
Increased adrenal glucocorticoid production leading to MASLD progression (5) |
You Song |
BY-SA |
None
|
None
|
|
|
| 633 |
Increased adrenal glucocorticoid production leading to MASLD progression (4) |
You Song |
BY-SA |
None
|
None
|
|
|
| 632 |
Increased adrenal glucocorticoid production leading to MASLD progression (3) |
You Song |
BY-SA |
None
|
None
|
|
|
| 631 |
Decreased thyroid hormone receptor beta transcriptional activity leading to MASLD progression via endoplasmic reticulum stress |
You Song |
BY-SA |
None
|
None
|
|
|
| 630 |
Decreased 11β-Hydroxysteroid dehydrogenase type 2 activity leading to MASLD progression via insulin resistance-associated mitochondrial dysfunction |
You Song |
BY-SA |
2409: Decrease, 11β-Hydroxysteroid dehydrogenase type 2 activity
|
None
|
Under Development |
|
| 629 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via lipogenesis-associated endoplasmic reticulum stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 628 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via lipogenesis-associated oxidative stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 627 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via lipogenesis-associated mitochondrial dysfunction |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 626 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via insulin resistance-associated endoplasmic reticulum stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|